Targeted therapy for lung cancer
Targeted therapy drugs are designed to attach themselves to specific receptors and proteins unique to cancer cells. Targeted therapy may be used alone, in combination with other types of targeted therapies or with other lung cancer treatments, such as chemotherapy, radiation therapy or interventional pulmonology.
Common targeted therapy drugs used to treat some lung cancers include gefitinib (Iressa®), crizotinib (Xalkori®) and erlotinib (Tarceva®). These drugs, called kinase inhibitors, target specific enzymes that help regulate cell growth.
Your doctor may also recommend bevacizumab (Avastin®), a monoclonal antibody and angiogenesis inhibitor that may prevent cancer cells from developing new blood vessels.